Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The prevalence and prognostic value of concomitant eosinophilia in chronic graft-versus-host disease after allogeneic stem cell transplantation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Biochemical abnormalities among patients referred for celiac disease antibody blood testing in a primary health care setting

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Severity and 90-day survival of SARS-CoV-2 infection among patients with haematological disorders

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

Vis graf over relationer
The prognostic significance of eosinophilia after myeloablative allogeneic stem cell transplantation (ASCT) remains to be established. Patients, whom developed chronic graft-versus-host disease (cGVHD) after ASCT, were included (n=142). Eosinophil count was analyzed at cGVHD onset. We observed no significant association between EO and the grade of cGVHD, thrombocytopenia, nor extensive skin involvement. Importantly, we observed no significant association between cGVHD with concomitant eosinophilia and long-term clinical outcomes, and subgroup analyses revealed a considerable confounding effect of ongoing steroid treatment. In conclusion, we advocate that prognostic conclusions regarding cGVHD with concomitant eosinophilia after ASCT should be interpreted with caution.
OriginalsprogEngelsk
TidsskriftLeukemia Research
Vol/bind38
Udgave nummer3
Sider (fra-til)334-339
ISSN0145-2126
DOI
StatusUdgivet - 2014

ID: 42572202